Market Tracker

10/02 4:09am ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.99
Data as of Oct 01
 -0.20 / -3.85%
Today’s Change
3.10
Today|||52-Week Range
7.45
-6.38%
Year-to-Date

Today’s Trading

Previous close5.19
Today’s open5.21
Day’s range-- - --
Volume1,125,557
Average volume (3 months)1,150,610
Market cap$361.0M
Dividend yield--
Data as of 10/01/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+97.37%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book4.00

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...0.000.00%
VNDAVanda Pharmaceutical...-0.22-2.12%
SUPNSupernus Pharmaceuti...-0.32-3.68%
PETXAratana Therapeutics...-0.45-4.48%
Data as of 10/01/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts